FDA Section 5 \u2022 cited verbatim

Icatibant - Warnings and Precautions

The following warnings and precautions are taken directly from the US FDA-approved drug label for Icatibant. This is the same information dispensing pharmacists read.

5 WARNINGS AND PRECAUTIONS Laryngeal attacks: Following treatment of laryngeal attacks with SAJAZIR, advise patients to seek immediate medical attention.

5.1 Laryngeal Attacks Given the potential for airway obstruction during acute laryngeal HAE attacks, patients should be advised to seek medical attention in an appropriate healthcare facility immediately in addition to treatment with SAJAZIR.

Applies to YOU?

Some warnings apply only to specific age groups, health conditions, or other medicines. Ask GoDavaii AI to filter which of these 2+ warnings apply to your profile.

Ask Health AI \u2192